CHF6.72
0.96% today
SIX Swiss Exchange, Jun 13, 10:42 am CET
ISIN
CH0042615283
Symbol
DOCM

DocMorris Stock price

CHF6.79
-1.98 22.55% 1M
-6.12 47.41% 6M
-3.05 31.04% YTD
-23.35 77.49% 1Y
-96.62 93.44% 5Y
-71.95 91.38% 10Y
-71.95 91.38% 20Y
SIX Swiss Exchange, Closing price Thu, Jun 12 2025
+0.03 0.37%
ISIN
CH0042615283
Symbol
DOCM
Sector

Key metrics

Market capitalization CHF263.26m
Enterprise Value CHF519.56m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.40
P/S ratio (TTM) P/S ratio 0.20
P/B ratio (TTM) P/B ratio 1.09
Revenue (TTM) Revenue CHF1.30b
EBIT (operating result TTM) EBIT CHF-117.70m
Free Cash Flow (TTM) Free Cash Flow CHF-86.54m
Cash position CHF67.07m
EPS (TTM) EPS CHF-5.11
P/E forward negative
P/S forward 0.22
EV/Sales forward 0.44
Show more

Is DocMorris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

DocMorris Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a DocMorris forecast:

4x Buy
36%
6x Hold
55%
1x Sell
9%

Analyst Opinions

11 Analysts have issued a DocMorris forecast:

Buy
36%
Hold
55%
Sell
9%

Financial data from DocMorris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,298 1,298
-
100%
- Direct Costs 1,020 1,020
-
79%
278 278
-
21%
- Selling and Administrative Expenses 125 125
-
10%
- Research and Development Expense - -
-
-
-60 -60
-
-5%
- Depreciation and Amortization 58 58
-
4%
EBIT (Operating Income) EBIT -118 -118
-
-9%
Net Profit -122 -122
-
-9%

In millions CHF.

Don't miss a Thing! We will send you all news about DocMorris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DocMorris Stock News

AD HOC NEWS
9 days ago
Die Baader Bank hat DocMorris CH0042615283 im Zuge der verbesserten finanziellen Stabilität der Online-Apotheke von "Reduce" auf "Add" hochgestuft.
AD HOC NEWS
17 days ago
Hauck Aufhäuser Investment Banking hat das Kursziel für DocMorris CH0042615283 nach einer Kapitalerhöhung von 60 auf 15 Franken angepasst und die Einstufung auf "Buy" belassen.
AD HOC NEWS
23 days ago
DocMorris AG / CH0042615283
More DocMorris News

Company Profile

DocMorris Ltd. engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. It operates through the following geograpical segments: Switzerland, Germany, and Europe. The company was founded by Walter Oberhänsli on April 6, 1993 and is headquartered in Frauenfeld, Switzerland.

Head office Switzerland
CEO Walter Hess
Employees 1,454
Founded 1993
Website corporate.docmorris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today